Effect of edaravone on myocardial injury in rats with chronic heart failure by regulating Notch/Hes-1 signaling pathway

WANG Chang-zong HONG Ling-ling CHEN Yi-yuan

Acta Anatomica Sinica ›› 2025, Vol. 56 ›› Issue (1) : 95-104.

PDF(16121 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(16121 KB)
Acta Anatomica Sinica ›› 2025, Vol. 56 ›› Issue (1) : 95-104. DOI: 10.16098/j.issn.0529-1356.2025.01.013
Histology,Embryology and Developmental Biology

Effect of edaravone on myocardial injury in rats with chronic heart failure by regulating Notch/Hes-1 signaling pathway

  • WANG Chang-zong HONG Ling-ling* CHEN Yi-yuan
Author information +
History +

Abstract

Objective To investigate the effect and mechanism of edaravone (Eda) on myocardial injury in chronic heart failure (CHF) rats by regulating Notch/Hes-1 signaling pathway.   Methods The CHF rat model was established and the rats were separated into sham surgery (S) group, model(M) group, low dose Eda (Eda-L) group, medium dose Eda (Eda-M) group, high dose Eda (Eda-H) group, and Eda-H + Notch signal pathway inhibitor DAPT (Eda-H + DAPT) group, with 25 rats in each group. Echocardiography was applied to detect the levels of left ventricular end diastolic diameter (LVEDd), left ventricular end-systolic diameter (LVEDs), and left ventricular ejection fraction (LVEF) in rats. ELISA was applied to detect levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, malondialdehyde (MDA), superoxide dismutase (SOD), and angiotensin Ⅱ (Ang Ⅱ) in serum. Myocardial infarction was observed by 2,3,5-triphenyl tetrazolium chloride(TTC) staining. HE staining, TUNEL staining and Masson staining were applied to observe the morphological changes of myocardial tissue, myocardial cell apoptosis and myocardial fibrosis respectively. immunohistochemistry was applied to detect the expression of collagen Ⅰ and angiotensin converting enzyme 2 (ACE2) proteins in myocardial tissue. Western blotting was applied to detect the expression of Notch 1, Hes-1, transforming growth factor-β1 (TGF-β1), Bcl-2, Bax, and Caspase-3 proteins in myocardial tissue.   Results Compared with the sham group, the distribution of cardiomyocytes in model group was disordered, and severe inflammatory symptoms. There was a large amount of blue collagen deposition between the perivascular area and the myocardium. The LVEDd, LVEDs, TNF-α, IL-1β, IL-6, MDA and Ang Ⅱ levels, myocardial infarction size, cardiomyocyte apoptosis rate, Collagen Ⅰ, Bax, Caspase-3 and TGF-β1 protein expressions increased obviously (P<0.05), the LVEF, SOD levels, ACE2, Bcl-2, Notch 1, and Hes-1 protein expressions were obviously reduced (P<0.05). Compared with the model group, the myocardial tissue damage was reduced in the Eda-L, Eda-M, and Eda-H groups, with reduced inflammatory cell infiltration and collagen deposition; The LVEDd, LVEDs, TNF-α, IL-1β, IL-6, MDA and Ang Ⅱ levels, myocardial infarction size, cardiomyocyte apoptosis rate, collagen Ⅰ, Bax, Caspase-3 and TG-β1 protein expressions reduced obviously(P<0.05), the LVEF, SOD levels, ACE2, Bcl-2, Notch 1, and Hes-1 protein expressions increased obviously (P<0.05). Notch signaling pathway inhibitor DAPT reversed the protective effect of edaravone on myocardial injury in rats with CHF (P<0.05).   Conclusion Edaravone may improve myocardial injury in CHF rats by activating Notch/Hes- 1 signaling pathway.

Key words

 Edaravone
/ Notch/Hes-1 signal pathway / Chronic heart failure / Myocardial damage / Immunohistochemistry / Rat 

Cite this article

Download Citations
WANG Chang-zong HONG Ling-ling CHEN Yi-yuan. Effect of edaravone on myocardial injury in rats with chronic heart failure by regulating Notch/Hes-1 signaling pathway[J]. Acta Anatomica Sinica. 2025, 56(1): 95-104 https://doi.org/10.16098/j.issn.0529-1356.2025.01.013

References

[1]Yin J, Lu X, Qian Z, et al. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure[J]. Theranostics, 2019, 9(14):4019-4029.
[2]Dang R, Wang M, Li X, et al. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway[J]. J Neuroinflammation, 2022, 19(1):41.
[3]Chen H, Chen Y, Wang X, et al. Edaravone attenuates myocyte apoptosis through the JAK2/STAT3 pathway in acute myocardial infarction[J]. Free Radic Res, 2020, 54(5):351-359.
[4]Wang L, Zeng YQ, Gu JH, et al. Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway[J]. Eur J Pharmacol, 2022, 920:174846. 
[5]Zeng C, Shao Z, Wei Z, et al. The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation[J]. Cell Mol Biol Lett, 2021, 26(1):7.
[6]Zhang Q, Wang L, Wang S, et al. Signaling pathways and targeted therapy for myocardial infarction[J]. Signal Transduct Target Ther, 2022, 7(1):78.
[7]Liu Y, Wang H, Wang X, et al. MiR-29b inhibits ventricular remodeling by activating notch signaling pathway in the rat myocardial infarction model[J]. Heart Surg Forum, 2019, 22(1): E019-E023.
[8]Guo P, Yi H, Han M, et al. Dexmedetomidine alleviates myocardial ischemia-reperfusion injury by down-regulating miR-34b-3p to activate the Jagged1/Notch signaling pathway[J]. Int Immunopharmacol, 2023, 116:109766.
[9]Gorjipour F, Hosseini-Gohari L, Alizadeh Ghavidel A, et al. Mesenchymal stem cells from human amniotic membrane differentiate into cardiomyocytes and endothelial-like cells without improving cardiac function after surgical administration in rat model of chronic heart failure[J]. J Cardiovasc Thorac Res, 2019, 11(1):35-42.
[10]Zhang WW, Bai F, Wang J, et al. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin Ⅱ AT1 receptor[J]. Drug Des Devel Ther, 2017, 11(1):3019-3033.
[11]Liu PY, Chen RR, Zhou HJ, et al. Effect of berbamine hydrochloride on myocardial injury in myocardial infarction mice and its molecular mechanism[J]. Shandong Medical Journal, 2021, 61(23):6-9. (in Chinese)
刘鹏云, 陈蕊蕊, 周海佳, 等. 盐酸小檗胺对心肌梗死小鼠心肌损伤的影响及其分子机制[J]. 山东医药, 2021, 61(23):6-9.
[12]Alem MM. Endothelial dysfunction in chronic heart failure: assessment, findings, significance, and potential therapeutic targets[J]. Int J Mol Sci, 2019, 20(13):3198.
[13]Homma T, Kobayashi S, Sato H, et al. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro[J]. Exp Cell Res, 2019, 384(1):111592.
[14]Liang XY, Gu Y, Zhao M, et al. Edaravone intervening the proliferation and differentiation of neural stem cells in rats with permanent cerebral ischemia[J]. Acta Anatomica Sinica, 2021, 52(3):370-376. (in Chinese)
梁晓艳, 顾玉, 赵梦, 等. 依达拉奉干预永久性脑缺血大鼠神经干细胞增殖及分化[J]. 解剖学报, 2021, 52(3):370-376.
[15]Hassan MQ, Akhtar MS, Afzal O, et al. Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity[J]. Clin Exp Hypertens, 2020, 42(5):381-392.
[16]Ma A, Hong J, Shanks J, et al. Upregulating Nrf2 in the RVLM ameliorates sympatho-excitation in mice with chronic heart failure[J]. Free Radic Biol Med, 2019, 141(1):84-92.
[17]Ghionzoli N, Gentile F, Del Franco AM, et al. Current and emerging drug targets in heart failure treatment[J]. Heart Fail Rev, 2022, 27(4):1119-1136.
[18]Ramchand J, Patel SK, Kearney LG, et al. Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis[J]. JACC Cardiovasc Imaging, 2020, 13(3):655-664.
[19]Chen RR, Fan XH, Chen G, et al. Irisin attenuates angiotensin Ⅱ-induced cardiac fibrosis via Nrf2 mediated inhibition of ROS/TGFbeta1/Smad2/3 signaling axis[J]. Chem Biol Interact, 2019, 302(1):11-21.
[20]Mahmoudi MJ, Hedayat M, Taghvaei M, et al. Interleukin-10 and transforming growth factor beta1 gene polymorphisms in chronic heart failure[J]. Acta Biomed, 2019, 90(2):221-227.
[21]Nikolov A, Popovski N. Extracellular matrix in heart disease: focus on circulating collagen type Ⅰ and Ⅲ derived peptides as biomarkers of myocardial fibrosis and their potential in the prognosis of heart failure: A concise review[J]. Metabolites, 2022, 12(4):297.
[22]Kachanova O, Lobov A, Malashicheva A. The role of the Notch signaling pathway in recovery of cardiac function after myocardial infarction[J]. Int J Mol Sci, 2022, 23(20):12509.
[23]Huang H, Lai S, Luo Y, et al. Nutritional preconditioning of apigenin alleviates myocardial ischemia/reperfusion injury via the mitochondrial pathway mediated by Notch1/Hes1[J]. Oxid Med Cell Longev, 2019, 2019:7973098.
[24]Lu Y, Li SY, Lou H. Patchouli alcohol protects against myocardial ischaemia-reperfusion injury by regulating the Notch1/Hes1 pathway[J]. Pharm Biol, 2022, 60(1):949-957.
[25]Zhou WW, Dai C, Liu WZ, et al. Gentianella acuta improves TAC-induced cardiac remodelling by regulating the Notch and PI3K/Akt/FOXO1/3 pathways[J]. Biomed Pharmacother, 2022, 154:113564. 

PDF(16121 KB)

Accesses

Citation

Detail

Sections
Recommended

/